READ

Could Octopuses Hold the Key to Curing Cancer?

An ink-redible discovery in the battle against melanoma.
Mia Georgiou
Mia Georgiou
Freelance Writer
Could Octopuses Hold the Key to Curing Cancer?

Scientific breakthroughs often emerge from unexpected and unlikely places. The development of penicillin was an accident, Velcro was inspired by plant burrs and multiple cancer treatments have been developed from sea sponges

New research has found that compounds from two different types of octopus may offer new ways to treat cancer. 

EIGHT ARMS, ENDLESS POSSIBILITIES

The octopuses in question are the Australian southern sand octopus and the common octopus, the same species featured in Netflix’s Oscar award-winning documentary My Octopus Teacher

Compounds in their venom and ink have been observed killing harmful microbes and fighting tumours.

The sand octopus’s special compound is called octopeptide-1. The common octopus’s secret compound is called ozopromide

Unlike other cancer treatments, the compounds in the octopus ink and venom target cancerous cells without harming healthy cells. 


Caption: A common octopus
Credit @robinr724 via Instagram

REDUCING RELAPSES

Dr Maria Ikonomopoulou is Head of the Translational Venomics Group at IMDEA-Food Institute in Madrid. She specialises in venom-based drug discovery. 

Maria led the research that discovered the sand octopus venom could attack melanoma. 

“What we found most exciting was the specificity of octopeptide-1,” says Maria.

“It wasn’t an aggressive method of killing melanoma cells. Cancer patients often can’t finish their treatment courses because they are too aggressive. This results in high relapse rates. 

“If a safer and more mild treatment option with less side effects was developed, more relapses could be prevented.”

The octopus venom is still being tested in animals, but early results are promising. 

Where usual cancer treatments aim to stop cancerous growths by killing them, this new treatment simply limits their growth

It is hoped this compound could be used as part of combined therapies for melanoma in the future. It could improve the target of existing treatments and make them less toxic to patients.

INK-REDIBLE MEDICINE

It is hoped the newly discovered compound in the common octopus’s ink could produce similar results. 

While it has slowed the growth of cancer cells from the breast, cervix, prostate and lungs in a lab environment, it hasn’t been tested on people yet.

The most effective results were a 50% reduction in the growth of lung cancer cells.

Similarly to the sand octopus venom, the common octopus ink specifically targeted cancerous cells, with nearby normal cells remaining unaffected. 

Caption: Maria in the lab
Credit: Supplied Maria Ikonomopoulou

SAFETY FIRST

“Unfortunately, getting to human trials is very slow progress,” says Maria. 

“There is a lot of research needed to make sure what we put into our bodies is safe and effective. A lot of time, resources and funding is needed – and funding is difficult to get.” 

Both compounds have been artificially created in the lab. This overcomes the challenge of relying on octopuses as a natural source.

More experiments using both compounds are required to take this research to the next step. 

There is still so much to be discovered within our oceans. From cancer treatments to renewable energy, the world – and ocean – is our oyster.

Mia Georgiou
About the author
Mia Georgiou
Mia loves intertwining the science and storytelling. She has worked as a medical copywriter and scriptwriter, for companies including NovoNordisk, Merck and Bristol Myers Squib. Away from her desk, Mia runs a sustainable swimwear brand and spends a lot of time diving, surfing and practising yoga.
View articles
Mia loves intertwining the science and storytelling. She has worked as a medical copywriter and scriptwriter, for companies including NovoNordisk, Merck and Bristol Myers Squib. Away from her desk, Mia runs a sustainable swimwear brand and spends a lot of time diving, surfing and practising yoga.
View articles

NEXT ARTICLE

We've got chemistry, let's take it to the next level!

Get the latest WA science news delivered to your inbox, every fortnight.

This field is for validation purposes and should be left unchanged.

Republish

Creative Commons Logo

Republishing our content

We want our stories to be shared and seen by as many people as possible.

Therefore, unless it says otherwise, copyright on the stories on Particle belongs to Scitech and they are published under a Creative Commons Attribution-NoDerivatives 4.0 International License.

This allows you to republish our articles online or in print for free. You just need to credit us and link to us, and you can’t edit our material or sell it separately.

Using the ‘republish’ button on our website is the easiest way to meet our guidelines.

Guidelines

You cannot edit the article.

When republishing, you have to credit our authors, ideally in the byline. You have to credit Particle with a link back to the original publication on Particle.

If you’re republishing online, you must use our pageview counter, link to us and include links from our story. Our page view counter is a small pixel-ping (invisible to the eye) that allows us to know when our content is republished. It’s a condition of our guidelines that you include our counter. If you use the ‘republish’ then you’ll capture our page counter.

If you’re republishing in print, please email us to let us so we know about it (we get very proud to see our work republished) and you must include the Particle logo next to the credits. Download logo here.

If you wish to republish all our stories, please contact us directly to discuss this opportunity.

Images

Most of the images used on Particle are copyright of the photographer who made them.

It is your responsibility to confirm that you’re licensed to republish images in our articles.

Video

All Particle videos can be accessed through YouTube under the Standard YouTube Licence.

The Standard YouTube licence

  1. This licence is ‘All Rights Reserved’, granting provisions for YouTube to display the content, and YouTube’s visitors to stream the content. This means that the content may be streamed from YouTube but specifically forbids downloading, adaptation, and redistribution, except where otherwise licensed. When uploading your content to YouTube it will automatically use the Standard YouTube licence. You can check this by clicking on Advanced Settings and looking at the dropdown box ‘License and rights ownership’.
  2. When a user is uploading a video he has license options that he can choose from. The first option is “standard YouTube License” which means that you grant the broadcasting rights to YouTube. This essentially means that your video can only be accessed from YouTube for watching purpose and cannot be reproduced or distributed in any other form without your consent.

Contact

For more information about using our content, email us: particle@scitech.org.au

Copy this HTML into your CMS
Press Ctrl+C to copy